2Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles(SLN) for controlled drug delivery-drug release and release mechanism[J].Eur J Pharm Biopharm,1998,45(2) : 149. 被引量：1
3Zara G P, Bargoni A, Cavalli R, et al. Pharmacokinetics and tissue distribution of idarubicin - loaded solid lipid nanoparticles after duodenal administration to rats[J] .J Pharm Scien ,2002,91(5) : 1 324. 被引量：1
4Miglietta A, Cavalli R ,Bocca C, et al. Cellular uptake and cytotoxicity of solid lipid nanospheres incorporation doxorubicin or paclitaxel [ J ] . lnt J Pharm , 2000,210(1-2) :61. 被引量：1
5Westesen K,Bunjes H,Koch MHJ .Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentia[J] .J Control Release, 1997,48(2-3) :223. 被引量：1
6Heiati H,Tawashi R,Phillips NC.Drug retention and stability of solid lipid, nanoparticles containing azidothymidinepalmitate after autoclaving,storage and lyophilization [J] .J Microencapsul, 1998,15(2) : 173. 被引量：1
7Cavalli R ,Gasco MR ,Barresi AA, et al .Evaporative drying of aqueous dispersions of solid lipid nanoparticles[J]. Drug Dev Ind Pharm , 2001,27(9) : 919. 被引量：1
9Avraham H, Ernest VG, Danielle R, et al .Damage to the protein synthesizing apparatus in mouse liver in vivo by magnetocytolysis in the presence of hepatospecific magnetic nanoparticles[J] .J Magnetism and Magnetic Materials , 2002,248 (2) : 276. 被引量：1
10Li YP,Pei YY,Zhou ZH.Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-a carriers:pharmacokinetics and anti - tumor effects[J] .Biol Pharm Bull, 2001,24(6) : 662. 被引量：1
